Drug Safety Act Expands Withdrawal Authority; Final Decision Rests With Commissioner
This article was originally published in The Pink Sheet Daily
Executive Summary
The proposed FDA Safety Act would enable the Center for Postmarket Drug Evaluation & Research to call for a drug's withdrawal, with final authority retained by the FDA commissioner